Team:BIOSINT Mexico/pitch

From 2012e.igem.org

(Difference between revisions)
Line 171: Line 171:
                                 <p class="clr-1"><strong>Source data.</strong></p>
                                 <p class="clr-1"><strong>Source data.</strong></p>
                             </div>
                             </div>
-
                             <p>Continuous advances in biological science have led to the broadening of commercially available molecular biology reagents and equipment, from where many techniques, applications, products and services for both industry and laboratory have developed.</br></br>
+
                             <p>CICESE (enero-marzo, 2001). Contrataciones en términos de la ley de adquisiciones, arrendamientos y servicios del sector público. Recovered on october 16th of 2012, of http://transparencia.cicese.mx/operaciones_reportables_1ertrimestre_2011.pdf</br></br>
-
Latin America is a region with great potential in market development and expansion.</br></br>
+
Grupo de Desarrollo Regional del Tecnológico de Monterrey (2009). Las megatendencias tecnológicas actuales y su impacto en la identificación de oportunidades estratégicas de negocios. México: ITESM. ISBN: 978-607-7517-94-8</br></br>
-
 
+
INEGI (2012). Producción científica y tecnológica. Recovered on october 16th of 2012, of http://www.inegi.org.mx/Sistemas/temasV2/Default.aspx?s=est&c=19007</br></br>
-
Consolidating a Synthetic Biology enterprise that provides custom synthetically designed and optimized genes, recombinant proteins, and specialized biotechnological solutions in the region, would capture the existing market-share and at the same time would fuel the development of a fresh new market that currently remains underexploited.</br></br>
+
Pérez-Hermosillo, J. E., & Leal-García, C. (2009). Identificación de oportunidades estratégicas para el desarrollo de la Región Querétaro-Celaya. México: ITESM. ISBN: 978-607-7517-45-0</br></br>
-
 
+
Sistema de Información Empresarial Mexicano (2012). Estadísticas [database]. México. Recovered on october 7th of 2012, of http://www.siem.gob.mx/siem/portal/estadisticas/ActXedo.asp</br></br>
-
Kuxtal Biotech has identified the need for a company that supplies quality services with both speed and an excelling customer support. The opportunities for business development of genomic technologies in Mexico have been underrated. Kuxtal Biotech intends to get a grip on the already existing market, and develop it, by supplying quality products and services with on-time deliveries, validation, and technical assistance through all the research and project development process.
+
Moreno-Brid, J.C. y Ruiz-Nápoles, P. (2003). De La educación superior y el desarrollo económico en América Latina. UNESCO.</br></br>
 +
El Economista (2012, november 24th). Lanzarán cluster de biotecnología en Querétaro. Retrieved on april 22nd of 2012, from: http://eleconomista.com.mx/industrias/2010/11/24/lanzaran-cluster-biotecnologia</br></br>
 +
iGEM (2011). Regional jamboree. Retrieved on April 22nd of 2012, from: https://igem.org/Team_Wikis?year=2011</br></br>
 +
Possani, L. D. (2003). The past, present, and future of biotechnology in Mexico. Nature Publishing Group , 852-853.</br></br>
 +
Booth, W., Miroff, N., 2012.  Middle class is booming in a changing Mexico. The Washington Post. http://seattletimes.nwsource.com/avantgo/2017786810.html</br></br>
 +
iGEM. Identidad campus Querétaro (http://identidad.campusqueretaro.net/?s=igem).</br></br>
 +
Tecnológico de Monterrey. iTunesU (http://itunes.itesm.mx/).</br></br>
 +
2010 Global Synthetic Biology, Technology Surveillance Report, Asociación  Mexicana de Biología Sintética, AC., 2010.</br></br>
 +
Biotechnology, BBC Reports, 2011, Synthetic Biology: Emerging Global Markets, Report Code:BIO066B. http://www.bccresearch.com/report/global-synthetic-biology-markets-bio066b.html
</p>
</p>
                         </div>
                         </div>

Revision as of 03:14, 28 October 2012

Kuxtal

WHAT I CANNOT CREATE, I DO NOT UNDERSTAND RICHARD FEYNMAN’S
Mexico is located in the “Ring of Fire”.
It is one of the earth’s most violent earthquake and volcano zones.

Project Summary

Elevator pitch video

Business model.

Executive summary.

Continuous advances in biological science have led to the broadening of commercially available molecular biology reagents and equipment, from where many techniques, applications, products and services for both industry and laboratory have developed.

Latin America is a region with great potential in market development and expansion.



Consolidating a Synthetic Biology enterprise that provides custom synthetically designed and optimized genes, recombinant proteins, and specialized biotechnological solutions in the region, would capture the existing market-share and at the same time would fuel the development of a fresh new market that currently remains underexploited.


Regional Average 57.2/ Global Average 53.8/ Emerging Markets Average 51.3
Source: BMI 2012



Kuxtal Biotech has identified the need for a company that supplies quality services with both speed and an excelling customer support. The opportunities for business development of genomic technologies in Mexico have been underrated. Kuxtal Biotech intends to get a grip on the already existing market, and develop it, by supplying quality products and services with on-time deliveries, validation, and technical assistance through all the research and project development process.

Source data.

CICESE (enero-marzo, 2001). Contrataciones en términos de la ley de adquisiciones, arrendamientos y servicios del sector público. Recovered on october 16th of 2012, of http://transparencia.cicese.mx/operaciones_reportables_1ertrimestre_2011.pdf

Grupo de Desarrollo Regional del Tecnológico de Monterrey (2009). Las megatendencias tecnológicas actuales y su impacto en la identificación de oportunidades estratégicas de negocios. México: ITESM. ISBN: 978-607-7517-94-8

INEGI (2012). Producción científica y tecnológica. Recovered on october 16th of 2012, of http://www.inegi.org.mx/Sistemas/temasV2/Default.aspx?s=est&c=19007

Pérez-Hermosillo, J. E., & Leal-García, C. (2009). Identificación de oportunidades estratégicas para el desarrollo de la Región Querétaro-Celaya. México: ITESM. ISBN: 978-607-7517-45-0

Sistema de Información Empresarial Mexicano (2012). Estadísticas [database]. México. Recovered on october 7th of 2012, of http://www.siem.gob.mx/siem/portal/estadisticas/ActXedo.asp

Moreno-Brid, J.C. y Ruiz-Nápoles, P. (2003). De La educación superior y el desarrollo económico en América Latina. UNESCO.

El Economista (2012, november 24th). Lanzarán cluster de biotecnología en Querétaro. Retrieved on april 22nd of 2012, from: http://eleconomista.com.mx/industrias/2010/11/24/lanzaran-cluster-biotecnologia

iGEM (2011). Regional jamboree. Retrieved on April 22nd of 2012, from: https://igem.org/Team_Wikis?year=2011

Possani, L. D. (2003). The past, present, and future of biotechnology in Mexico. Nature Publishing Group , 852-853.

Booth, W., Miroff, N., 2012. Middle class is booming in a changing Mexico. The Washington Post. http://seattletimes.nwsource.com/avantgo/2017786810.html

iGEM. Identidad campus Querétaro (http://identidad.campusqueretaro.net/?s=igem).

Tecnológico de Monterrey. iTunesU (http://itunes.itesm.mx/).

2010 Global Synthetic Biology, Technology Surveillance Report, Asociación Mexicana de Biología Sintética, AC., 2010.

Biotechnology, BBC Reports, 2011, Synthetic Biology: Emerging Global Markets, Report Code:BIO066B. http://www.bccresearch.com/report/global-synthetic-biology-markets-bio066b.html

Retrieved from "http://2012e.igem.org/wiki/index.php/Team:BIOSINT_Mexico/pitch"